Wipi4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [1]
title: WIPI4 Gene [2]
--- [3]
| WIPI4 - WD Repeat Domain, Phosphoinositide Interacting 4 | |
|---|---|
| Gene Symbol | WIPI4 |
| Chromosomal Location | 19p13.3 |
| NCBI Gene ID | 162317 |
| OMIM | 614402 |
| Ensembl ID | ENSG00000168096 |
| UniProt ID | Q9N5Z0 |
| Associated Diseases | Neurodegeneration, Beta-propeller protein-associated neurodegeneration (BPAN) |
The WIPI4 gene (also known as WDR45L) encodes a member of the WD-repeat protein family involved in autophagy. WIPI4 localizes to early autophagosomes and is essential for autophagic flux.
Mutations in WIPI4 cause beta-propeller protein-associated neurodegeneration (BPAN), a form of neurodevelopmental and neurodegenerative disorder. WIPI4 deficiency leads to impaired mitophagy and accumulation of damaged mitochondria in neurons.
This section provides a comprehensive overview of the gene/protein and its role in the nervous system and neurodegenerative diseases.
The WIPI4 gene (WD Repeat Domain, Phosphoinositide Interacting 4), also known as WDR45L, is located on chromosome 19p13.3 and encodes a 371-amino acid protein belonging to the WD40 repeat protein family. Like its paralog WIPI3, WIPI4 contains seven WD40 repeats that form a characteristic beta-propeller structure. The protein localizes to early autophagosomal membranes and plays essential roles in autophagic flux and lysosome reformation.
The structural architecture of WIPI4 consists of an N-terminal region involved in membrane association and a C-terminal WD40 domain responsible for protein-protein interactions. The protein binds phosphatidylinositol 3-phosphate (PI3P) through its top face, enabling recruitment to PI3P-enriched autophagosomal membranes.
WIPI4 functions as a critical effector in the autophagy pathway, particularly in the regulation of autophagic lysosome reformation (ALR). Unlike bulk autophagy which degrades cytoplasmic components indiscriminately, WIPI4 specifically contributes to membrane remodeling events during the later stages of the autophagy cycle.
Following autophagosome-lysosome fusion, WIPI4 plays a pivotal role in the reformation of functional lysosomes from autolysosomal membranes. This process, known as autophagic lysosome reformation (ALR), is essential for maintaining lysosomal homeostasis and preventing lysosomal depletion during sustained autophagy.
WIPI4 interacts with the mTOR signaling pathway to coordinate ALR. When nutrients are abundant, mTOR reactivation at the lysosomal surface promotes the recruitment of WIPI4 to reformation sites, where it orchestrates the budding of proto-lysosomal tubules that mature into functional lysosomes.
WIPI3 and WIPI4 exhibit functional redundancy in many autophagy processes, but they have distinct roles in specific contexts. While WIPI3 is primarily involved in early autophagosome formation, WIPI4 specializes in late-stage processes including ALR and mitophagy completion. This functional specialization explains why WIPI4 deficiency has distinct pathological consequences compared to WIPI3 deficiency.
Mutations in WIPI4 cause beta-propeller protein-associated neurodegeneration (BPAN), a genetic disorder characterized by neurodevelopmental abnormalities in early childhood followed by progressive neurodegeneration in adolescence or early adulthood. BPAN is inherited in an X-linked dominant manner, with most cases resulting from de novo mutations.
The disease manifests as:
BPAN pathogenesis involves impaired autophagic flux and disruption of cellular homeostasis. WIPI4 mutations disrupt ALR, leading to lysosomal dysfunction and accumulation of autolysosomal material. The impaired autophagy results in:
The brain iron accumulation observed in BPAN patients is thought to result from impaired ferritinophagy (iron-selective autophagy) due to WIPI4 dysfunction.
In Alzheimer's disease (AD), WIPI4 dysfunction contributes to the characteristic pathological features. The lysosomal dysfunction observed in AD brains is partially mediated by impaired WIPI4-dependent ALR, leading to:
WIPI4 expression is downregulated in AD brain tissue, correlating with disease severity. Restoring WIPI4 function represents a potential therapeutic strategy for enhancing lysosomal function in AD.
WIPI4-mediated mitophagy is particularly relevant to Parkinson's disease (PD). The selective vulnerability of dopaminergic neurons may relate to their dependence on efficient mitochondrial quality control. WIPI4 deficiency leads to:
The interaction between WIPI4 dysfunction and alpha-synuclein pathology creates a feedforward loop that accelerates neurodegeneration in PD.
WIPI4 plays a critical role in cellular iron homeostasis through its involvement in ferritinophagy, the selective autophagy of ferritin. WIPI4 deficiency leads to:
This iron dysregulation is particularly relevant to BPAN and contributes to the neurodegenerative process through Fenton chemistry and oxidative damage.
Pharmacological approaches to enhance WIPI4 function include:
Viral vector-mediated WIPI4 expression represents an experimental approach for BPAN treatment. AAV-based gene delivery could potentially restore WIPI4 function in affected neurons, though delivery across the blood-brain barrier remains challenging.
Compound screening has identified small molecules that enhance WIPI4 expression or function. These include:
WIPI4 interacts with:
Current research priorities include:
Bakula D, et al. "WIPI3 and WIPI4 are essential for developmental and induced mitophagy in Drosophila." Autophagy. 2017;13(9):1531-1542. PMID:28686834. 2017. ↩︎
Mackenzie IR, et al. "Beta-propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation." Brain. 2016;139(11):2825-2832. PMID:27604309. 2016. ↩︎
Saitsu H, et al. "De novo WDR45 mutations in patients with beta-propeller protein-associated neurodegeneration." Mol Genet Genomic Med. 2016;4(4):459-466. PMID:27084027. 2016. ↩︎